Alembic Pharma's Q2 net halves to Rs 169 cr as US biz takes 40% dip

Dragged by the price erosion in the US market, Alembic Pharmaceuticals Limited has posted a fall of nearly 50 per cent in its net profit for the second quarter ended September 30, 2021. The company registered a net profit of Rs 169.29 crore for the said quarter, as compared to Rs 333.37 crore in the corresponding period last year.

The company's revenue from operations too fell by 11 per cent to Rs 1,292.32 crore in Q2 of FY22, as against Rs 1,457.10 crore in Q2 of FY21. In terms of business segments, while price erosion due to greater competition saw its